Eldri U. Due
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 2
-
- RNA Research and Splicing 2
- Advanced biosensing and bioanalysis techniques 1
- Co-authors
- Kristine Kleivi Sahlberg (7 shared papers)Anne‐Lise Børresen‐Dale (5 shared papers)Merja Perälä (3 shared papers)Olli Kallioniemi (4 shared papers)Rami Mäkelä (3 shared papers)Suvi‐Katri Leivonen (2 shared papers)Vesa Hongisto (3 shared papers)Henrik Edgren (3 shared papers)
- Journals
- Molecular Oncology (3 papers)European Journal of Cancer (2 papers)Breast Cancer Targets and Therapy (1 paper)BioTechniques (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- NorwayUnited StatesFinland
In The Last Decade
Eldri U. Due
11 papers receiving 439 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 292
- Oncology 133
- Molecular Biology 325
- Genetics 21
- Radiology, Nuclear Medicine and Imaging 38
Countries citing papers authored by Eldri U. Due
This map shows the geographic impact of Eldri U. Due's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eldri U. Due with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eldri U. Due more than expected).
Fields of papers citing papers by Eldri U. Due
This network shows the impact of papers produced by Eldri U. Due. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eldri U. Due. The network helps show where Eldri U. Due may publish in the future.
Co-authors
The 25 scholars most cited alongside Eldri U. Due, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 146 | |
| 2 | 2012 | 69 | |
| 3 | 2016 | 56 | |
| 4 | 2011 | 44 | |
| 5 | 2014 | 35 | |
| 6 | 2015 | 25 | |
| 7 | 2017 | 24 | |
| 8 | 2009 | 23 | |
| 9 | 2005 | 19 | |
| 10 | 2012 | 1 | |
| 11 | 2014 | 1 |
About Eldri U. Due
Eldri U. Due is a scholar working on Cancer Research, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 11 papers that have together received 443 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers), RNA Research and Splicing (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Cancer Research (292 citations), Oncology (133 citations), Molecular Biology (325 citations), Genetics (21 citations) and Radiology, Nuclear Medicine and Imaging (38 citations). Eldri U. Due has collaborated with scholars based in Norway, United States and Finland. Frequent co-authors include Kristine Kleivi Sahlberg, Anne‐Lise Børresen‐Dale, Merja Perälä, Olli Kallioniemi, Rami Mäkelä, Suvi‐Katri Leivonen, Vesa Hongisto, Henrik Edgren, Hans Kristian Moen Vollan and Sandra Jernström. Their work appears in journals such as Molecular Oncology, European Journal of Cancer, Breast Cancer Targets and Therapy, BioTechniques and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.